US Pharma MarketingAxsome fends off generic competition to narcolepsy med Sunosi until 2040
With a new patent settlement, Axsome Therapeutics can lower its sword against prospective generics makers taking aim at its narcolepsy med Sunosi. The company inked another settlement with a prospective generic maker, leaving no further pending patent litigation for its Sunosi on the table.
The company inked another settlement with a prospective generic maker, leaving no further pending patent litigation for its Sunosi on the table.
Source: FiercePharma